Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China

BACKGROUND: β-Thalassemia major (β-TM) has become a public health problem in mainland China. Hematopoietic stem cell transplantation (HSCT) has remained the only cure for β-TM in mainland China since 1998. METHODS: This multicenter retrospective study provides a comprehensive review of the outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin-Yu, Sun, Xin, Chen, Jing, Qin, Mao-Quan, Luan, Zuo, Zhu, Yi-Ping, Fang, Jian-Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Childrens Hospital, Zhejiang University School of Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861180/
https://www.ncbi.nlm.nih.gov/pubmed/29511925
http://dx.doi.org/10.1007/s12519-017-0107-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861180/
https://www.ncbi.nlm.nih.gov/pubmed/29511925
http://dx.doi.org/10.1007/s12519-017-0107-5

Ejemplares similares